Key result
Sirtuin-1 expression was significantly associated with shorter overall survival in patients with liposarcoma (HR 3.752; 95% CI 1.553-9.062).
Why the study?
Although sirtuin-1 is linked to the growth and survival of malignant tumors, its prognostic value alongside VEGF expression in liposarcoma remained unclear.
Does sirtuin-1 and VEGF expression predict poor prognosis and tumor progression in patients with liposarcoma?
Cohort (n=42)
Does sirtuin-1 and VEGF expression predict poor prognosis and tumor progression in patients with liposarcoma?
Sirtuin-1 expression is significantly correlated with tumor progression and serves as an independent predictor of poor overall survival in patients with liposarcoma.
Answers are grounded in this paper and cite their sources.
Sirtuin-1 may support prognostic stratification in liposarcoma; leaves open therapeutic implications pending prospective validation.
OBJECTIVES: A relationship exists between sirtuin-1 expression and growth and survival of malignant tumors. This study aimed to investigate the prognostic value of sirtuin-1 and vascular endothelial growth factor (VEGF) expression in patients with liposarcoma by examining associations between their expression levels and clinical outcomes. METHODS: Clinical and histopathological characteristics and follow-up and survival information were retrospectively reviewed for 42 liposarcoma cases. Sirtuin-1 and VEGF protein expression levels were evaluated by immunohistochemistry and their associations with clinical parameters were analyzed using the Spearman-rho test. Univariate and multivariate Cox regression analyses were performed to identify potential prognostic factors. Kaplan-Meier analysis was performed to analyze overall survival. RESULTS: Sirtuin-1 and VEGF protein expression levels were significantly associated with histological grade, metastasis, and American Joint Committee on Cancer stage. A significant positive correlation was observed between sirtuin-1 and VEGF expression levels (R = 0.677). In univariate analysis, sirtuin-1 and VEGF expression were correlated with shorter overall survival, but the association was significant only for sirtuin-1 (hazard ratio = 3.752, 95% confidence interval 1.553-9.062) in multivariate analysis. CONCLUSION: Sirtuin-1 and VEGF expression levels are significantly correlated with progression of liposarcoma, and sirtuin-1 expression significantly predicts a poor prognosis in patients with liposarcoma.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2020) conducted a cohort in Liposarcoma (n=42). Sirtuin-1 and VEGF expression was evaluated on Overall survival (HR 3.752, 95% CI 1.553-9.062). Sirtuin-1 expression was significantly associated with shorter overall survival in patients with liposarcoma (HR 3.752; 95% CI 1.553-9.062).
Synapse has enriched 10 related papers. Consider them for comparative context: